T lymphocytes reactive with as yet undefined joint-localized foreign or autoantigens may be important in the pathogenesis of RA. Molecular studies demonstrating skewed T cell antigen receptor (TCR) variable gene usage and selective expansion of particular T cell clones within the synovial compartment support this view. Based on our recent study documenting selective expansion of V1317+ T cells in RA, we have pursued the identification of T cells relevant to the disease process, in an informative patient, by combining molecular analysis of freshly explanted RA synovial tissue V(317 TCR transcripts with in vitro expansion of V,B17+ synovial tissue T cell clones. Peripheral blood V/317 cDNA transcripts proved heterogeneous. In contrast, two closely related sequences, not found in the peripheral blood, dominated synovial tissue V,f17 transcripts, suggesting selective localization and oligoclonal expansion at the site of pathology. CD4+, V.817+ synovial tissue-derived T cell clones, isolated and grown in vitro, were found to express TCR 8 chain transcripts homologous to the dominant Vj817 synovial tissue sequences. One clone shares with a dominant synovial tissue sequence a conserved cluster of 4/5 amino acids (IGQ-N) in the highly diverse antigen binding CDR3 region, suggesting that the T cells from which these transcripts derive may recognize the same antigen. These findings have permitted a complete characterization of the cr/ f8 TCR expressed by putatively pathogenic T cell clones in RA. Functional analysis suggests that the conserved CDR3 sequence may confer specificity for, or restriction by, the MHC class II antigen, DR4. (J. Clin. Invest. 1994. 94:2525-2531
Introduction
Many cell types, notably macrophages, synoviocytes, and polymorphonuclear leukocytes, participate in the complex inflam-matory response that effects joint destruction in RA. However, a central role for T lymphocytes is suggested by (a) the rich infiltration of activated T cells at the primary site of disease activity, the synovial tissue (1, 2); (b) genetic studies linking RA disease susceptibility to a defined amino acid sequence in the third hypervariable region of the DR/3 chain of the MHC class II molecule (3, 4) ; (c) animal models of chronic arthritis in which antigen-specific T cells are capable of transferring disease to naive recipients (5, 6) ; and (d) amelioration of arthritis, both in murine models of autoimmune disease and in patients with RA, by administration of mAb reactive with the CD4+ T cell subset (7, 8) .
While the importance of T cells in RA appears clear, neither the antigen specificity nor the function of disease-inducing T cells has been determined. In an attempt to identify and characterize pathogenic T cells among the vast number present in the inflamed joint, investigators have applied molecular techniques to detect T cells which (a) share T cell antigen receptor (TCR)' structural features, i.e., restricted usage of particular TCR variable gene elements, or (b) are "oligoclonal" with respect to the highly polymorphic antigen binding CDR3 region of the TCR, suggesting antigen-driven expansion at the site of pathology. To date, this approach has yielded conflicting results. Several laboratories have reported evidence of oligoclonality and over-usage of particular TCR V gene products among RA jointderived T cells (9) (10) (11) . However, the TCR V gene families implicated vary from study to study and still other investigators find no evidence for TCR skewing in RA (12, 13) .
To directly evaluate TCR V gene usage in the RA T cell repertoire, we have used the available panel of mAbs specific for particular human TCR chain variable region (TCR V, 6) gene products (14) . Our results demonstrate selective expansion of the V,317+ T cell population, both systemically and in the joint, in a significant percentage of RA patients, as compared to both normals and non-RA arthritis controls. 15 of 49 (31%) RA synovial fluids, but 0 of 19 non-RA control samples, contained > 10% V,817+ T cells (14) . Moreover, even RA synovial fluid samples which did not contain a numerically expanded V/317 + population showed evidence for the preferential activation (IL-2 receptor expression) of CD4 + VP317 + T cells. Taken together, these data suggest a role for V,617+ T cells in RA. To further address this issue, we have analyzed an informative RA patient who exhibits a persistently expanded V317+ peripheral T cell population. While the V/I17 expression in this patient's peripheral blood T cells proved quite heterogeneous, we have identified a group of closely related joint-derived V,17 sequences, including those that dominated the freshly isolated synovial tissue and fluid. These V,817 transcripts are highly homologous in the CDR3 antigen binding region, suggesting that T cells from which these transcripts derive may be driven by a common joint-localized antigen. The isolation and in vitro propagation of T cell clones expressing the consensus CDR3 motif has allowed complete characterization of the a/I TCR expressed by potentially pathogenic T cells in RA.
Methods
RA patient. B.C. is a 74-yr-old white female with a 22-yr history of rheumatoid factor (RF) positive RA. Clinical features of her disease include a history of joint pain and swelling, morning stiffness, fatigue, and dry eyes. Physical examination showed symmetric synovitis involving the left elbow; bilateral wrists, metacarpalphalangeal, and proximal interphalangeal joints; bilateral knees; and right ankle. In addition, ulnar deviation and nodular tenosynovitis of the hands were observed, and a subcutaneous nodule was present on the extensor surface of the left elbow. Laboratory analysis was normal except for an erythrocyte sedimentation rate of 33 and a positive RF. X rays of the hands showed erosions of the distal ulna and radius bilaterally and knee x rays showed osteopenia, joint space narrowing, and lateral osteophytes. Over the course of her disease, the patient had been treated with intramuscular gold, methotrexate, plaquenil, non-steroidal anti-inflammatory drugs, and low dose prednisone. She (16) . The sense 5' primer for Va2 was 5' AAGGTTTACAGCACAGCTC 3'. The PCR was performed 30 cycles each consisting of a 1 -min denaturation step at 94°C, a 1-min annealing step at 56°C, and a 1.5-min extension step at 72°C. After 30 cycles the reaction mixtures were prolonged at 72°C for 10 min. The PCR products were subcloned into a T/A cloning vector (Invitrogen) following the instruction manual provided by the company. The ligation mixture was used to transform the competent cells DH5a. The plasmid DNA samples were prepared using a quick protocol ( 15 (Fig. 3) . Taken together, these data demonstrate that in the face of a longstanding, polyclonal systemic expansion of V,617 + T cells, particular CD4+, VP/17+ T cell clones expressing structurally related CDR3 sequences localize to and expand in the inflamed synovial compartment.
In vitro propagation of VP17+ synovial T cell clones. To examine the possible role played by T cells expressing these dominant V/17 sequences in the rheumatoid process, we attempted to isolate and expand these cells in vitro. Freshly isolated ST T cells were cultured in the presence of IL-2 alone for 1 wk, then activated by the VP617 selective microbial superantigen (Fig. 5) . The V,B17 transcript from clone C5-2 was named V,617seq4 (Fig. 4 A) . Although the motif IGQ does not appear, the amino acid residue I at position 95 and N at position 99 are shared with V,6l17seql, 2, and 3 ( Fig. 5) . Moreover, 
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quences from two ST-derived T cell clone sequenced shares usage of the J,62.1 gene segment. In this regard, it should be noted that residue Asn ("N") at position 99 is encoded by the germline J/32.1 segment used by V,/17seq2, 3, and 4. However, the N at the same position in V,B17seql, which uses J/32.7, is not germline encoded, but results from the process of N region nucleotide addition which generates diversity in the antigen binding VDJ junctional region (19) . Our results strongly suggest that the T cells represented by the two dominant ST V317 transcripts and the homologous transcripts from T cell clones, in particular CS-1, recognize the same jointlocalized antigen and that conserved CDR3 amino acids of the TCR / chain may prove crucial for antigen recognition. TCR a expression in Vf317+ synovial T cell clones. As antigen recognition is a function of both the TCR a and ,B chains, we next characterized a chain usage by synovial tissue derived T cell clones CS-1 and CS-2. TCR a rearrangements have been analyzed by PCR using a panel of Va specific primers in connection with a TCR a constant region primer (16) . This analysis revealed expression of only Va2.3 by the T cell clone CS-1. Formal sequencing was performed and yielded a sequence consisting of Va2.3-Ja(IGRJaO9) -Ca (Fig. 4 B) . This Va designation is consistent with positive staining of this T cell clone by the Va2.3 specific mAb Fl (20) . Expression of Va2.3 is of interest, as recent reports have shown the selective increase in Va2.3 + T cells in the synovial fluid of some RA patients (21, 22) . A similar analysis of T cell clone C5-2 which expresses the VP I7seq4 has yielded a TCR a rearrangement of Va3. -JakCa (Fig. 4 B) . Of interest, these two a chains are quite homologous in the CDR3 loop, sharing a pair of G residues at positions 96 and 97, as well as N at position 99 (Fig. 5) (Fig. 6 B) . The response can be selectively inhibited by anti-DR mAb (data not shown). This preliminary evidence of DR4 recognition by synovial T cells expressing the conserved CDR3 sequences is intriguing. Additional studies will be needed to determine if these T cell clones are specific for the DR4 alleles themselves, or for joint-derived or EBV-encoded peptides presented on the DR4 molecules. In this regard, a five amino acid region of homology between the EBV gpl 10 protein and the RA MHC class II disease susceptibility epitope has been noted and proposed to be potentially relevant to the pathogenesis of RA (23) .
Discussion
Previous studies designed to correlate TCR structure with antigen-MHC molecular complex recognition have emphasized the importance of critical amino acid residues in each of the three polymorphic CDR regions of both a and /3 chains, with the N-D-N region of CDR3 playing a dominant role. In both the murine and human systems, T cells specific for a particular peptide-MHC complex often use a restricted group of TCR V (stl) VI317seql JB2.7 sion Nos. U07134-35, 37-38, and U07636-37). specific TCRs which have incorporated reciprocal charge changes in the N-D-N region of CDR3 (amino acid residues 95-99) of both the a and ,3 chains (25) . This result suggests that these TCR residues bind directly to the antigenic peptide. In a related study, it was found that the murine TCR repertoire recognizing foreign peptides which are highly homologous to self is markedly constrained with respect to TCR Va and VP3 gene usage, CDR3 length, and the presence of canonical amino acid residues in the CDR3 domain (26, 27) .
These data suggest that antigen-driven pathogenic T cells mediating autoimmune disease might be expected to express TCR which share crucial structural characteristics. This situation obtains for the myelin basic protein (MBP) specific Th cells which induce experimental allergic encephalomyelitis (28) (29) (30) . Encephalitogenic T cell clones are strongly biased with respect to V3 and Va gene usage as well as CDR3 region structure ( 31 ). Recently, it has been shown that TCR V,f transcripts isolated from central nervous system lesions of patients with multiple sclerosis exhibit sequence motifs in the N-D-N region homologous with those expressed by encephalitogenic MBP reactive murine T cell clones (32, 33) .
Extension of this concept to T cells mediating other autoimmune diseases, including RA, remains controversial. Oligoclonal expansions of V/33, 14, and 17 bearing synovial T cells in RA (9) (10) (11) , as well as VP14 in juvenile rheumatoid arthritis (34) have been described. In this study, we have identified the RA joint specific localization of several closely related V/317 + T cells, including those expressing the oligoclonal sequences which dominated fresh ST and SF. The TCR Vf17 expressed 0 700 1400 2100 2800 3500 LC5-2 (Val3.I/VPI7seq4) l
